Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
human |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Dasoveanu DC |
Year: |
2020 |
Journal: |
Sci Immunol |
Title: |
Lymph node stromal CCL2 limits antibody responses. |
Volume: |
5 |
Issue: |
45 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Bray JG |
Year: |
2017 |
Journal: |
Neuroscience |
Title: |
Transgenic mice with increased astrocyte expression of CCL2 show altered behavioral effects of alcohol. |
Volume: |
354 |
|
Pages: |
88-100 |
|
•
•
•
•
•
|
Publication |
First Author: |
Godefroy D |
Year: |
2012 |
Journal: |
Toxicol Sci |
Title: |
The chemokine CCL2 protects against methylmercury neurotoxicity. |
Volume: |
125 |
Issue: |
1 |
Pages: |
209-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cédile O |
Year: |
2014 |
Journal: |
J Autoimmun |
Title: |
Thymic CCL2 influences induction of T-cell tolerance. |
Volume: |
55 |
|
Pages: |
73-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qian BZ |
Year: |
2011 |
Journal: |
Nature |
Title: |
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. |
Volume: |
475 |
Issue: |
7355 |
Pages: |
222-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gutiérrez IL |
Year: |
2022 |
Journal: |
Int J Mol Sci |
Title: |
CCL2 Inhibition of Pro-Resolving Mediators Potentiates Neuroinflammation in Astrocytes. |
Volume: |
23 |
Issue: |
6 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Li F |
Year: |
2019 |
Journal: |
Cancer Res |
Title: |
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretion. |
Volume: |
79 |
Issue: |
15 |
Pages: |
3903-3915 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nakayama A |
Year: |
2023 |
Journal: |
J Exp Med |
Title: |
Suppression of CCL2 angiocrine function by adrenomedullin promotes tumor growth. |
Volume: |
220 |
Issue: |
1 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Jiang Q |
Year: |
2020 |
Journal: |
JCI Insight |
Title: |
Elevated CCL2 causes Leydig cell malfunction in metabolic syndrome. |
Volume: |
5 |
Issue: |
21 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ge S |
Year: |
2008 |
Journal: |
J Neurochem |
Title: |
Transcellular transport of CCL2 across brain microvascular endothelial cells. |
Volume: |
104 |
Issue: |
5 |
Pages: |
1219-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee CP |
Year: |
2019 |
Journal: |
J Cell Mol Med |
Title: |
ALPK1 regulates streptozotocin-induced nephropathy through CCL2 and CCL5 expressions. |
Volume: |
23 |
Issue: |
11 |
Pages: |
7699-7708 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jung YJ |
Year: |
2015 |
Journal: |
J Am Soc Nephrol |
Title: |
SIRT2 Regulates LPS-Induced Renal Tubular CXCL2 and CCL2 Expression. |
Volume: |
26 |
Issue: |
7 |
Pages: |
1549-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stamatovic SM |
Year: |
2006 |
Journal: |
J Immunol |
Title: |
CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. |
Volume: |
177 |
Issue: |
4 |
Pages: |
2651-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Miyabe C |
Year: |
2019 |
Journal: |
J Clin Invest |
Title: |
Dectin-2-induced CCL2 production in tissue-resident macrophages ignites cardiac arteritis. |
Volume: |
129 |
Issue: |
9 |
Pages: |
3610-3624 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kiyota T |
Year: |
2009 |
Journal: |
PLoS One |
Title: |
CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction. |
Volume: |
4 |
Issue: |
7 |
Pages: |
e6197 |
|
•
•
•
•
•
|
Publication |
First Author: |
Whelan DS |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
Mesenchymal stromal cell derived CCL2 is required for accelerated wound healing. |
Volume: |
10 |
Issue: |
1 |
Pages: |
2642 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kashyap S |
Year: |
2018 |
Journal: |
Sci Rep |
Title: |
Ccl2 deficiency protects against chronic renal injury in murine renovascular hypertension. |
Volume: |
8 |
Issue: |
1 |
Pages: |
8598 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim RY |
Year: |
2014 |
Journal: |
J Neuroimmunol |
Title: |
Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis. |
Volume: |
274 |
Issue: |
1-2 |
Pages: |
53-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schuster C |
Year: |
2020 |
Journal: |
Eur J Immunol |
Title: |
S1PR4-dependent CCL2 production promotes macrophage recruitment in a murine psoriasis model. |
Volume: |
50 |
Issue: |
6 |
Pages: |
839-845 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kwon MJ |
Year: |
2015 |
Journal: |
J Neurosci |
Title: |
CCL2 Mediates Neuron-Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury. |
Volume: |
35 |
Issue: |
48 |
Pages: |
15934-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Held KS |
Year: |
2004 |
Journal: |
Virology |
Title: |
Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. |
Volume: |
329 |
Issue: |
2 |
Pages: |
251-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yuda K |
Year: |
2012 |
Journal: |
Am J Pathol |
Title: |
Adrenomedullin inhibits choroidal neovascularization via CCL2 in the retinal pigment epithelium. |
Volume: |
181 |
Issue: |
4 |
Pages: |
1464-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee SW |
Year: |
2013 |
Journal: |
Brain Behav Immun |
Title: |
Absence of CCL2 is sufficient to restore hippocampal neurogenesis following cranial irradiation. |
Volume: |
30 |
|
Pages: |
33-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Diaz-Guerra E |
Year: |
2007 |
Journal: |
J Immunol |
Title: |
CCL2 inhibits the apoptosis program induced by growth factor deprivation, rescuing functional T cells. |
Volume: |
179 |
Issue: |
11 |
Pages: |
7352-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Luhmann UF |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling. |
Volume: |
7 |
Issue: |
4 |
Pages: |
e35551 |
|
•
•
•
•
•
|
Publication |
First Author: |
Orchanian SB |
Year: |
2024 |
Journal: |
PLoS Pathog |
Title: |
Deficiency in astrocyte CCL2 production reduces neuroimmune control of Toxoplasma gondii infection. |
Volume: |
20 |
Issue: |
1 |
Pages: |
e1011710 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maeda A |
Year: |
2015 |
Journal: |
Bone |
Title: |
Induction of CXCL2 and CCL2 by pressure force requires IL-1β-MyD88 axis in osteoblasts. |
Volume: |
74 |
|
Pages: |
76-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sasaki Y |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
NOX4 Regulates CCR2 and CCL2 mRNA Stability in Alcoholic Liver Disease. |
Volume: |
7 |
|
Pages: |
46144 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsui P |
Year: |
2007 |
Journal: |
Hum Antibodies |
Title: |
Generation, characterization and biological activity of CCL2 (MCP-1/JE) and CCL12 (MCP-5) specific antibodies. |
Volume: |
16 |
Issue: |
3-4 |
Pages: |
117-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kiyota T |
Year: |
2013 |
Journal: |
Neurobiol Aging |
Title: |
CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease. |
Volume: |
34 |
Issue: |
4 |
Pages: |
1060-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Van Steenwinckel J |
Year: |
2015 |
Journal: |
Brain Behav Immun |
Title: |
Stromal cell-derived CCL2 drives neuropathic pain states through myeloid cell infiltration in injured nerve. |
Volume: |
45 |
|
Pages: |
198-210 |
|
•
•
•
•
•
|
Publication |
First Author: |
Elhofy A |
Year: |
2005 |
Journal: |
J Leukoc Biol |
Title: |
Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis. |
Volume: |
77 |
Issue: |
2 |
Pages: |
229-37 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saito S |
Year: |
2011 |
Journal: |
Am J Pathol |
Title: |
Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage. |
Volume: |
179 |
Issue: |
3 |
Pages: |
1088-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kriegel MA |
Year: |
2012 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells. |
Volume: |
109 |
Issue: |
9 |
Pages: |
3457-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tang X |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
Novel regulation of CCL2 gene expression by murine LITAF and STAT6B. |
Volume: |
6 |
Issue: |
9 |
Pages: |
e25083 |
|
•
•
•
•
•
|
Publication |
First Author: |
Swiecki M |
Year: |
2017 |
Journal: |
Mucosal Immunol |
Title: |
Microbiota induces tonic CCL2 systemic levels that control pDC trafficking in steady state. |
Volume: |
10 |
Issue: |
4 |
Pages: |
936-945 |
|
•
•
•
•
•
|
Publication |
First Author: |
Du S |
Year: |
2022 |
Journal: |
J Clin Invest |
Title: |
A nerve injury-specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression. |
Volume: |
132 |
Issue: |
13 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ge S |
Year: |
2009 |
Journal: |
J Mol Neurosci |
Title: |
Astrocyte- and endothelial-targeted CCL2 conditional knockout mice: critical tools for studying the pathogenesis of neuroinflammation. |
Volume: |
39 |
Issue: |
1-2 |
Pages: |
269-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chun E |
Year: |
2015 |
Journal: |
Cell Rep |
Title: |
CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function. |
Volume: |
12 |
Issue: |
2 |
Pages: |
244-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qiu C |
Year: |
2020 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Cortistatin protects against inflammatory airway diseases through curbing CCL2 and antagonizing NF-κB signaling pathway. |
Volume: |
531 |
Issue: |
4 |
Pages: |
595-601 |
|
•
•
•
•
•
|
Publication |
First Author: |
Flaishon L |
Year: |
2008 |
Journal: |
Blood |
Title: |
Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions. |
Volume: |
112 |
Issue: |
13 |
Pages: |
5016-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sierra-Filardi E |
Year: |
2014 |
Journal: |
J Immunol |
Title: |
CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile. |
Volume: |
192 |
Issue: |
8 |
Pages: |
3858-67 |
|
•
•
•
•
•
|
Publication |
First Author: |
Le Thuc O |
Year: |
2016 |
Journal: |
EMBO Rep |
Title: |
Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation. |
Volume: |
17 |
Issue: |
12 |
Pages: |
1738-1752 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim BH |
Year: |
2023 |
Journal: |
Sci Rep |
Title: |
CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice. |
Volume: |
13 |
Issue: |
1 |
Pages: |
6577 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen M |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice. |
Volume: |
6 |
Issue: |
8 |
Pages: |
e22818 |
|
•
•
•
•
•
|
Publication |
First Author: |
Roy RM |
Year: |
2012 |
Journal: |
J Immunol |
Title: |
Chitin elicits CCL2 from airway epithelial cells and induces CCR2-dependent innate allergic inflammation in the lung. |
Volume: |
189 |
Issue: |
5 |
Pages: |
2545-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Klueh U |
Year: |
2016 |
Journal: |
Biosens Bioelectron |
Title: |
Impact of CCL2 and CCR2 chemokine/receptor deficiencies on macrophage recruitment and continuous glucose monitoring in vivo. |
Volume: |
86 |
|
Pages: |
262-269 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lu H |
Year: |
2011 |
Journal: |
FASEB J |
Title: |
Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. |
Volume: |
25 |
Issue: |
10 |
Pages: |
3344-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen M |
Year: |
2012 |
Journal: |
Glia |
Title: |
Para-inflammation-mediated retinal recruitment of bone marrow-derived myeloid cells following whole-body irradiation is CCL2 dependent. |
Volume: |
60 |
Issue: |
5 |
Pages: |
833-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kiguchi N |
Year: |
2013 |
Journal: |
Cytokine |
Title: |
Epigenetic upregulation of CCL2 and CCL3 via histone modifications in infiltrating macrophages after peripheral nerve injury. |
Volume: |
64 |
Issue: |
3 |
Pages: |
666-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giraud SN |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. |
Volume: |
107 |
Issue: |
18 |
Pages: |
8416-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kalderén C |
Year: |
2012 |
Journal: |
Biochem Pharmacol |
Title: |
A truncated analogue of CCL2 mediates anti-fibrotic effects on murine fibroblasts independently of CCR2. |
Volume: |
83 |
Issue: |
5 |
Pages: |
644-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Khan UA |
Year: |
2016 |
Journal: |
J Cell Biochem |
Title: |
CCL2 and CCR2 are Essential for the Formation of Osteoclasts and Foreign Body Giant Cells. |
Volume: |
117 |
Issue: |
2 |
Pages: |
382-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jia P |
Year: |
2022 |
Journal: |
Am J Physiol Renal Physiol |
Title: |
Chemokine CCL2 from proximal tubular epithelial cells contributes to sepsis-induced acute kidney injury. |
Volume: |
323 |
Issue: |
2 |
Pages: |
F107-F119 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jablonska J |
Year: |
2007 |
Journal: |
Infect Immun |
Title: |
Essential role of CCL2 in clustering of splenic ERTR-9+ macrophages during infection of BALB/c mice by Listeria monocytogenes. |
Volume: |
75 |
Issue: |
1 |
Pages: |
462-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang H |
Year: |
2020 |
Journal: |
Neurosci Bull |
Title: |
Spinal CCL2 Promotes Pain Sensitization by Rapid Enhancement of NMDA-Induced Currents Through the ERK-GluN2B Pathway in Mouse Lamina II Neurons. |
Volume: |
36 |
Issue: |
11 |
Pages: |
1344-1354 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ford LB |
Year: |
2014 |
Journal: |
J Immunol |
Title: |
Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes. |
Volume: |
193 |
Issue: |
1 |
Pages: |
400-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vessey KA |
Year: |
2015 |
Journal: |
Invest Ophthalmol Vis Sci |
Title: |
Assessment of retinal function and morphology in aging Ccl2 knockout mice. |
Volume: |
56 |
Issue: |
2 |
Pages: |
1238-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jablonski CL |
Year: |
2019 |
Journal: |
J Orthop Res |
Title: |
CCL2 But Not CCR2 Is Required for Spontaneous Articular Cartilage Regeneration Post-Injury. |
Volume: |
37 |
Issue: |
12 |
Pages: |
2561-2574 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bicer F |
Year: |
2015 |
Journal: |
Am J Physiol Renal Physiol |
Title: |
Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model. |
Volume: |
308 |
Issue: |
2 |
Pages: |
F103-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rafei M |
Year: |
2008 |
Journal: |
Blood |
Title: |
Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. |
Volume: |
112 |
Issue: |
13 |
Pages: |
4991-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Roblek M |
Year: |
2019 |
Journal: |
Mol Cancer Res |
Title: |
CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis. |
Volume: |
17 |
Issue: |
3 |
Pages: |
783-793 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wolter S |
Year: |
2008 |
Journal: |
Mol Cell Biol |
Title: |
c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene. |
Volume: |
28 |
Issue: |
13 |
Pages: |
4407-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Moreno M |
Year: |
2014 |
Journal: |
J Neurosci |
Title: |
Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. |
Volume: |
34 |
Issue: |
24 |
Pages: |
8175-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ninichuk V |
Year: |
2008 |
Journal: |
Am J Pathol |
Title: |
Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice. |
Volume: |
172 |
Issue: |
3 |
Pages: |
628-37 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim SM |
Year: |
2015 |
Journal: |
Biochim Biophys Acta |
Title: |
27-Hydroxycholesterol up-regulates CD14 and predisposes monocytic cells to superproduction of CCL2 in response to lipopolysaccharide. |
Volume: |
1852 |
Issue: |
3 |
Pages: |
442-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen HJ |
Year: |
2024 |
Journal: |
Brain Behav Immun |
Title: |
Fetal CCL2 signaling mediates offspring social behavior and recapitulates effects of prenatal stress. |
Volume: |
115 |
|
Pages: |
308-318 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giri J |
Year: |
2020 |
Journal: |
Cell Rep |
Title: |
CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury. |
Volume: |
30 |
Issue: |
6 |
Pages: |
1923-1934.e4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kiyota T |
Year: |
2015 |
Journal: |
Brain Behav Immun |
Title: |
Presenilin-1 familial Alzheimer's disease mutation alters hippocampal neurogenesis and memory function in CCL2 null mice. |
Volume: |
49 |
|
Pages: |
311-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee HK |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms. |
Volume: |
7 |
|
Pages: |
41258 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sato S |
Year: |
2014 |
Journal: |
J Immunol |
Title: |
A circadian clock gene, Rev-erbα, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression. |
Volume: |
192 |
Issue: |
1 |
Pages: |
407-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bardina SV |
Year: |
2015 |
Journal: |
J Immunol |
Title: |
Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection. |
Volume: |
195 |
Issue: |
9 |
Pages: |
4306-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wacker BK |
Year: |
2012 |
Journal: |
J Neurochem |
Title: |
Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway. |
Volume: |
123 |
Issue: |
6 |
Pages: |
954-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang AL |
Year: |
2016 |
Journal: |
Cancer Res |
Title: |
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. |
Volume: |
76 |
Issue: |
19 |
Pages: |
5671-5682 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zahner G |
Year: |
2009 |
Journal: |
Biochem J |
Title: |
Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation. |
Volume: |
422 |
Issue: |
3 |
Pages: |
563-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kwiatkowski K |
Year: |
2019 |
Journal: |
Cytokine |
Title: |
Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia. |
Volume: |
119 |
|
Pages: |
202-213 |
|
•
•
•
•
•
|
Publication |
First Author: |
Joly-Amado A |
Year: |
2020 |
Journal: |
Front Immunol |
Title: |
CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy. |
Volume: |
11 |
|
Pages: |
997 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shigematsu K |
Year: |
2012 |
Journal: |
Eur J Immunol |
Title: |
Effect of CCL2 antisense oligodeoxynucleotides on bacterial translocation and subsequent sepsis in severely burned mice orally infected with Enterococcus faecalis. |
Volume: |
42 |
Issue: |
1 |
Pages: |
158-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jimenez F |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. |
Volume: |
184 |
Issue: |
10 |
Pages: |
5571-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Panoskaltsis-Mortari A |
Year: |
2004 |
Journal: |
Am J Physiol Lung Cell Mol Physiol |
Title: |
Post-BMT lung injury occurs independently of the expression of CCL2 or its receptor, CCR2, on host cells. |
Volume: |
286 |
Issue: |
2 |
Pages: |
L284-92 |
|
•
•
•
•
•
|
Publication |
First Author: |
Song Y |
Year: |
2012 |
Journal: |
Arterioscler Thromb Vasc Biol |
Title: |
Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. |
Volume: |
32 |
Issue: |
1 |
Pages: |
103-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Darisipudi MN |
Year: |
2011 |
Journal: |
Am J Pathol |
Title: |
Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. |
Volume: |
179 |
Issue: |
1 |
Pages: |
116-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
van Gemst JJ |
Year: |
2018 |
Journal: |
PLoS One |
Title: |
Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains. |
Volume: |
13 |
Issue: |
9 |
Pages: |
e0201560 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shigematsu K |
Year: |
2009 |
Journal: |
J Leukoc Biol |
Title: |
Enterococcus faecalis translocation in mice with severe burn injury: a pathogenic role of CCL2 and alternatively activated macrophages (M2aMphi and M2cMphi). |
Volume: |
86 |
Issue: |
4 |
Pages: |
999-1005 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dogan RN |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF- and iNOS-expressing macrophages and myeloid dendritic cells. |
Volume: |
180 |
Issue: |
11 |
Pages: |
7376-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Janssen K |
Year: |
2016 |
Journal: |
Mol Neurobiol |
Title: |
Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier. |
Volume: |
53 |
Issue: |
3 |
Pages: |
1551-1564 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bai Y |
Year: |
2008 |
Journal: |
Eur J Immunol |
Title: |
CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity. |
Volume: |
38 |
Issue: |
7 |
Pages: |
1877-88 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kalkonde YV |
Year: |
2007 |
Journal: |
Brain Res |
Title: |
Chemokines in the MPTP model of Parkinson's disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration. |
Volume: |
1128 |
Issue: |
1 |
Pages: |
1-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lehmann MH |
Year: |
2016 |
Journal: |
J Leukoc Biol |
Title: |
CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection. |
Volume: |
99 |
Issue: |
6 |
Pages: |
1057-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Niemi JP |
Year: |
2016 |
Journal: |
Exp Neurol |
Title: |
Overexpression of the monocyte chemokine CCL2 in dorsal root ganglion neurons causes a conditioning-like increase in neurite outgrowth and does so via a STAT3 dependent mechanism. |
Volume: |
275 Pt 1 |
|
Pages: |
25-37 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
65
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Schober A |
Year: |
2004 |
Journal: |
Circ Res |
Title: |
Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. |
Volume: |
95 |
Issue: |
11 |
Pages: |
1125-33 |
|
•
•
•
•
•
|
GO Term |
|
•
•
•
•
•
|